{"id":"https://openalex.org/W7127611044","doi":"https://doi.org/10.1097/yct.0000000000001223","title":"Effects of Dual Orexin Receptor Antagonists on Seizure Quality in Modified Electroconvulsive Therapy","display_name":"Effects of Dual Orexin Receptor Antagonists on Seizure Quality in Modified Electroconvulsive Therapy","publication_year":2026,"publication_date":"2026-02-04","ids":{"openalex":"https://openalex.org/W7127611044","doi":"https://doi.org/10.1097/yct.0000000000001223","pmid":"https://pubmed.ncbi.nlm.nih.gov/41637492"},"language":"en","primary_location":{"id":"doi:10.1097/yct.0000000000001223","doi":"https://doi.org/10.1097/yct.0000000000001223","is_oa":false,"landing_page_url":"https://doi.org/10.1097/yct.0000000000001223","pdf_url":null,"source":{"id":"https://openalex.org/S164150133","display_name":"Journal of Ect","issn_l":"1095-0680","issn":["1095-0680","1533-4112"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of ECT","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5076520486","display_name":"Yuichi Shimohara","orcid":"https://orcid.org/0000-0003-2336-1709","observed_orcids":["https://orcid.org/0000-0003-2336-1709"]},"institutions":[{"id":"https://openalex.org/I4405284972","display_name":"Osaka Psychiatric Medical Center","ror":"https://ror.org/04j4q9j26","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4405284972"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yuichi Shimohara","raw_affiliation_strings":["Department of Psychiatry, Osaka Psychiatric Medical Center, Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, Osaka Psychiatric Medical Center, Osaka, Japan","institution_ids":["https://openalex.org/I4405284972"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5124316946","display_name":"Taro Matsuda","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405284972","display_name":"Osaka Psychiatric Medical Center","ror":"https://ror.org/04j4q9j26","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4405284972"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Taro Matsuda","raw_affiliation_strings":["Department of Psychiatry, Osaka Psychiatric Medical Center, Osaka, Japan","Supplemental Digital Content is available for this article. Direct URL citations are provided in the HTML and PDF versions of this article on the journal's website, www.ectjournal.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, Osaka Psychiatric Medical Center, Osaka, Japan","institution_ids":["https://openalex.org/I4405284972"]},{"raw_affiliation_string":"Supplemental Digital Content is available for this article. Direct URL citations are provided in the HTML and PDF versions of this article on the journal's website, www.ectjournal.com","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5124362868","display_name":"Kazuhiko Iwata","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405284972","display_name":"Osaka Psychiatric Medical Center","ror":"https://ror.org/04j4q9j26","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4405284972"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kazuhiko Iwata","raw_affiliation_strings":["Department of Psychiatry, Osaka Psychiatric Medical Center, Osaka, Japan","Supplemental Digital Content is available for this article. Direct URL citations are provided in the HTML and PDF versions of this article on the journal's website, www.ectjournal.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, Osaka Psychiatric Medical Center, Osaka, Japan","institution_ids":["https://openalex.org/I4405284972"]},{"raw_affiliation_string":"Supplemental Digital Content is available for this article. Direct URL citations are provided in the HTML and PDF versions of this article on the journal's website, www.ectjournal.com","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4405284972"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0758267,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11921","display_name":"Electroconvulsive Therapy Studies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11921","display_name":"Electroconvulsive Therapy Studies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10614","display_name":"Transcranial Magnetic Stimulation Studies","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dual-orexin-receptor-antagonists","display_name":"dual orexin receptor antagonists","score":0.9959999918937683},{"id":"https://openalex.org/keywords/modified-electroconvulsive-therapy","display_name":"modified electroconvulsive therapy","score":0.9819999933242798},{"id":"https://openalex.org/keywords/seizure-quality","display_name":"seizure quality","score":0.9959999918937683},{"id":"https://openalex.org/keywords/suvorexant","display_name":"suvorexant","score":0.9380000233650208},{"id":"https://openalex.org/keywords/lemborexant","display_name":"lemborexant","score":0.9980000257492065},{"id":"https://openalex.org/keywords/landiolol","display_name":"landiolol","score":0.8360000252723694},{"id":"https://openalex.org/keywords/clozapine","display_name":"clozapine","score":0.7549999952316284},{"id":"https://openalex.org/keywords/peak-heart-rate","display_name":"peak heart rate","score":0.8569999933242798},{"id":"https://openalex.org/keywords/eeg-coherence","display_name":"EEG coherence","score":0.8519999980926514},{"id":"https://openalex.org/keywords/seizure-duration","display_name":"seizure duration","score":0.625},{"id":"https://openalex.org/keywords/older-adults","display_name":"older adults","score":0.49300000071525574}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7523999810218811},{"id":"https://openalex.org/C2777330709","wikidata":"https://www.wikidata.org/wiki/Q131543","display_name":"Electroconvulsive therapy","level":3,"score":0.6633999943733215},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.5583999752998352},{"id":"https://openalex.org/C2779384505","wikidata":"https://www.wikidata.org/wiki/Q17007513","display_name":"Concomitant","level":2,"score":0.5321000218391418},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4359000027179718},{"id":"https://openalex.org/C2778186239","wikidata":"https://www.wikidata.org/wiki/Q41571","display_name":"Epilepsy","level":2,"score":0.42879998683929443},{"id":"https://openalex.org/C2777010014","wikidata":"https://www.wikidata.org/wiki/Q852376","display_name":"Convulsion","level":3,"score":0.3813000023365021},{"id":"https://openalex.org/C2780980858","wikidata":"https://www.wikidata.org/wiki/Q110022","display_name":"Dual (grammatical number)","level":2,"score":0.36640000343322754},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.34209999442100525},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.31540000438690186},{"id":"https://openalex.org/C188816634","wikidata":"https://www.wikidata.org/wiki/Q2113324","display_name":"Prospective cohort study","level":2,"score":0.30820000171661377},{"id":"https://openalex.org/C2778460930","wikidata":"https://www.wikidata.org/wiki/Q7447053","display_name":"Seizure threshold","level":4,"score":0.2849000096321106},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.2759999930858612},{"id":"https://openalex.org/C100691959","wikidata":"https://www.wikidata.org/wiki/Q6410625","display_name":"Kindling","level":3,"score":0.2718999981880188},{"id":"https://openalex.org/C2778581513","wikidata":"https://www.wikidata.org/wiki/Q263962","display_name":"Transcranial magnetic stimulation","level":3,"score":0.2709999978542328},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.2621000111103058},{"id":"https://openalex.org/C2775858608","wikidata":"https://www.wikidata.org/wiki/Q576618","display_name":"Anticonvulsant","level":3,"score":0.25279998779296875}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1097/yct.0000000000001223","doi":"https://doi.org/10.1097/yct.0000000000001223","is_oa":false,"landing_page_url":"https://doi.org/10.1097/yct.0000000000001223","pdf_url":null,"source":{"id":"https://openalex.org/S164150133","display_name":"Journal of Ect","issn_l":"1095-0680","issn":["1095-0680","1533-4112"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of ECT","raw_type":"journal-article"},{"id":"pmid:41637492","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/41637492","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The journal of ECT","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"sustainable_development_goals_aurora":[],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":15,"referenced_works":["https://openalex.org/W1484997088","https://openalex.org/W1979416820","https://openalex.org/W2041538173","https://openalex.org/W2121960517","https://openalex.org/W2167343469","https://openalex.org/W2277207370","https://openalex.org/W2337338892","https://openalex.org/W2531909124","https://openalex.org/W2597374004","https://openalex.org/W2741571707","https://openalex.org/W2937592204","https://openalex.org/W4232062301","https://openalex.org/W4400977971","https://openalex.org/W4401195626","https://openalex.org/W4409120332"],"related_works":[],"abstract_inverted_index":{"OBJECTIVES:":[0],"Dual":[1],"orexin":[2],"receptor":[3],"antagonists":[4],"(DORAs)":[5],"are":[6,250],"widely":[7],"used":[8],"for":[9],"insomnia":[10],"treatment;":[11],"however,":[12],"their":[13,234],"effects":[14],"on":[15],"seizure":[16,31,80,158,189,231],"quality":[17,73,159],"during":[18,33,226],"modified":[19],"electroconvulsive":[20],"therapy":[21],"(m-ECT)":[22],"remain":[23],"unclear.":[24],"This":[25],"study":[26],"examined":[27],"whether":[28],"DORAs":[29],"influence":[30],"parameters":[32,160],"m-ECT.":[34],"METHODS:":[35],"A":[36],"total":[37],"of":[38,104],"239":[39],"m-ECT":[40,227],"sessions":[41],"in":[42,157],"54":[43],"patients":[44,129,169],"(January":[45],"2022":[46],"to":[47,135,148,175,181,252],"February":[48],"2025)":[49],"were":[50,54,155,191,196,239],"retrospectively":[51],"analyzed.":[52],"Patients":[53],"categorized":[55],"into":[56],"a":[57,65,99],"DORA":[58,185,204,224],"group":[59,67],"(32":[60],"patients,":[61,69],"152":[62],"sessions)":[63],"and":[64,87,98,123,144,200,202,244],"non-DORA":[66],"(22":[68],"87":[70],"sessions).":[71],"Seizure":[72],"was":[74],"assessed":[75],"using":[76],"postictal":[77],"suppression":[78],"index,":[79],"duration,":[81],"electroencephalogram":[82],"(EEG)":[83],"coherence,":[84],"EEG":[85],"amplitude,":[86],"peak":[88,178],"heart":[89],"rate":[90],"(HR).":[91],"Linear":[92],"mixed-effects":[93],"models":[94],"evaluated":[95],"each":[96],"parameter":[97],"composite":[100,163],"\u03a3z":[101,164],"score":[102,165],"(sum":[103],"standardized":[105],"z-scores)":[106],"with":[107,184,210],"covariates":[108],"including":[109],"age,":[110],"sex,":[111],"chlorpromazine-equivalent":[112],"dose,":[113,122],"diagnosis":[114],"(F2":[115],"vs.":[116,141],"non-F2),":[117],"ECT":[118],"session":[119],"number,":[120],"thiopental":[121],"percentage":[124],"energy.":[125],"Subgroup":[126],"analyses":[127,146,213],"included":[128],"aged":[130,170],"older":[131,171],"than":[132,172],"or":[133,161,173,217],"equal":[134,174],"60":[136,176],"years,":[137,177],"within-DORA":[138],"comparisons":[139],"(suvorexant":[140],"lemborexant,":[142,201],"dose-adjusted),":[143],"dose-response":[145,245],"limited":[147],"DORA-treated":[149],"sessions.":[150],"RESULTS:":[151],"No":[152,193],"significant":[153,194],"differences":[154,195],"observed":[156],"the":[162,203],"between":[166,198],"groups.":[167],"Among":[168],"HR":[179],"tended":[180],"be":[182],"lower":[183],"exposure,":[186],"whereas":[187],"EEG-based":[188],"measures":[190],"maintained.":[192],"found":[197],"suvorexant":[199],"dose":[205],"showed":[206],"no":[207],"linear":[208],"relationship":[209],"\u03a3z.":[211],"Sensitivity":[212],"excluding":[214],"landiolol,":[215],"clozapine,":[216],"non-F2/F3":[218],"diagnoses":[219],"yielded":[220],"consistent":[221,240],"results.":[222,255],"CONCLUSIONS:":[223],"use":[225],"did":[228],"not":[229],"impair":[230],"quality,":[232],"supporting":[233],"safe":[235],"concomitant":[236],"use.":[237],"Findings":[238],"across":[241],"subgroup,":[242],"agent,":[243],"analyses.":[246],"Larger":[247],"prospective":[248],"trials":[249],"warranted":[251],"confirm":[253],"these":[254]},"counts_by_year":[],"updated_date":"2026-10-09T09:14:12.587421","created_date":"2026-02-06T00:00:00"}